Abemaciclib, Palbociclib or Dalpiciclib Combined with Endocrine Therapy As First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer

NCT06344780 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fudan University